Streptomyces cytochromes P450: applications in drug metabolism

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Expert Opinion on Drug Metabolism & Toxicology

• Publication date

  2013-09-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1517/17425255.2013.806485PMID 23738914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What makes a P450 tick?

  2013cited by this paper
• Microbial cytochromes P450: biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us?

  2013cited by this paper
• Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.

  2012cited by this paper
• Structural Characterization of Human Cytochrome P450 2C19

  2012cited by this paper
• Orphans in the Human Cytochrome P450 Superfamily: Approaches to Discovering Functions and Relevance in Pharmacology

  2011cited by this paper
• Structural basis for conservation in the CYP51 family.

  2011cited by this paper
• Efficient Screening of Cytochrome P450 BM3 Mutants for Their Metabolic Activity and Diversity toward a Wide Set of Drug-Like Molecules in Chemical Space

  2011cited by this paper
• Regio- and Stereospecificity of Filipin Hydroxylation Sites Revealed by Crystal Structures of Cytochrome P450 105P1 and 105D6 from Streptomyces avermitilis*

  2010cited by this paper
• The Cytochrome P450 Homepage

  2009influential reference
• Steroidogenic enzymes.

  2008cited by this paper
• Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2*♦

  2007cited by this paper
• Safety assessment of drug metabolites: Characterization of chemically stable metabolites.

  2006cited by this paper
• Structural basis for ligand promiscuity in cytochrome P450 3A4

  2006cited by this paper
• Crystal Structure of Human Cytochrome P450 2D6*

  2005cited by this paper
• CYP2E1-dependent oxidative stress and toxicity: role in ethanol-induced liver injury

  2005cited by this paper
• Oxidative stress induces GSTP1 and CYP3A4 expression in the human erythroleukemia cell line, K562.

  2004cited by this paper
• Alosetron repeat dose pharmacokinetics, effects on enzyme activities, and influence of demographic factors

  2004influential reference
• Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids.

  2004cited by this paper
• Comparison of the 1.85 Å structure of CYP154A1 from Streptomyces coelicolor A3(2) with the closely related CYP154C1 and CYPs from antibiotic biosynthetic pathways

  2004cited by this paper
• Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone

  2004cited by this paper
• CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids.

  2004cited by this paper
• CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes ω- and (ω-1)-Hydroxylation of Fatty Acids*

  2004cited by this paper
• Crystal structure of human cytochrome P450 2C9 with bound warfarin

  2003cited by this paper
• Conservation and cloning of CYP51: a sterol 14α-demethylase from Mycobacterium smegmatis

  2003cited by this paper
• Evaluation of the toxicological relevance of CYP3A4 induction.

  2003cited by this paper
• Conservation and cloning of CYP51: a sterol 14 alpha-demethylase from Mycobacterium smegmatis.

  2003cited by this paper
• The metabolism of diclofenac--enzymology and toxicology perspectives.

  2003cited by this paper
• The 1.92-Å Structure of Streptomyces coelicolor A3(2) CYP154C1

  2003cited by this paper
• Summary of information on human CYP enzymes: human P450 metabolism data

  2002influential reference
• CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes.

  2002cited by this paper
• Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.

  2002cited by this paper
• Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker

  2002cited by this paper
• Cytochromes P450 and experimental models of drug metabolism

  2002cited by this paper
• The Cytochrome P450 Complement (CYPome) of Streptomyces coelicolor A3(2)*

  2002cited by this paper
• Problems associated with in vitro assessment of drug inhibition of CYP3A4 and other P-450 enzymes and its impact on drug discovery.

  2001cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• The sequence of the human genome (abstract only)

  2001cited by this paper
• Uncommon P450-catalyzed reactions.

  2001cited by this paper
• Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.

  2001cited by this paper
• Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity.

  2000cited by this paper
• Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis.

  1999cited by this paper
• The role of CYP2B6 in human xenobiotic metabolism.

  1999cited by this paper
• Kinetics of Cytochrome P450 2E1-Catalyzed Oxidation of Ethanol to Acetic Acid via Acetaldehyde*

  1999cited by this paper
• Microbial models for drug metabolism.

  1999influential reference
• Hydroxylation of macrolactones YC-17 and narbomycin is mediated by the pikC-encoded cytochrome P450 in Streptomyces venezuelae.

  1998cited by this paper
• Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.

  1998cited by this paper
• Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility.

  1997cited by this paper
• Different effects of inhibitors on the O - and N -demethylation of codeine in human liver microsomes

  1997cited by this paper
• Human P450 metabolism of warfarin.

  1997influential reference
• Novel metabolites of warfarin produced by Beauveria bassiana and Streptomyces rimosus: a novel application of hplc-nmr.

  1997cited by this paper
• Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.

  1997cited by this paper
• Phase I and phase II enzymes produced by Cunninghamella elegans for the metabolism of xenobiotics.

  1996cited by this paper
• Cytochrome P450: Structure, mechanism, and biochemistry

  1996cited by this paper
• Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.

  1996cited by this paper
• Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450.

  1996cited by this paper
• Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity.

  1996cited by this paper
• Fungal transformations of antihistamines: metabolism of brompheniramine, chlorpheniramine, and pheniramine to N-oxide and N-demethylated metabolites by the fungus Cunninghamella elegans.

  1995cited by this paper
• BIOTRANSFORMATION OF ALOSETRON : MECHANISM OF HYDANTOIN FORMATION

  1995cited by this paper
• Microbial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.

  1995cited by this paper
• Cytochrome P450.

  1995cited by this paper
• Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation.

  1994cited by this paper
• Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

  1994cited by this paper
• Cytochrome P450

  1993cited by this paper
• Metabolism of xenobiotics by Beauveria bassiana.

  1993cited by this paper
• Preparation of 10,11-Epoxy-carbamazepine and 10,11-Dihydro-10-hydroxy-carbamazepine by Microbial Epoxidation and Hydroxylation

  1993cited by this paper
• Cloning, nucleotide sequence determination and expression of the genes encoding cytochrome P‐450soy and ferredoxinsoy (soyB) from Streptomyces griseus

  1992influential reference
• Principles of biochemical toxicology

  1991influential reference
• The screening of selected microorganisms for use as models of mammalian drug metabolism

  1991cited by this paper
• Use of microorganisms for the study of drug metabolism: An update

  1991influential reference
• Activation of promutagenic chemicals by Streptomyces griseus containing cytochrome P-450soy.

  1990cited by this paper
• Lack of regio- and stereospecificity in oxidation of (+) camphor by Streptomyces griseus enriched in cytochrome P-450soy.

  1990cited by this paper
• Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene.

  1990cited by this paper
• Microbial metabolism studies of the antimalarial sesquiterpene artemisinin.

  1989cited by this paper
• Purification and characterization of a soybean flour-induced cytochrome P-450 from Streptomyces griseus

  1989cited by this paper
• Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI).

  1988influential reference
• Purification and reconstitution of the electron transport components for 6-deoxyerythronolide B hydroxylase, a cytochrome P-450 enzyme of macrolide antibiotic (erythromycin) biosynthesis

  1988cited by this paper
• Xenobiotic oxidation by cytochrome P-450-enriched extracts of Streptomyces griseus.

  1988cited by this paper
• Primary Structure of the P450 Lanosterol Demethylase Gene from Saccharomyces cerevisiae

  1987cited by this paper
• Induction of cytochrome P-450 in Streptomyces griseus by soybean flour.

  1986cited by this paper
• Sequence the Human Genome

  1986cited by this paper
• Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction.

  1986cited by this paper
• Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.

  1985cited by this paper
• Identification of transformation products arising from bacterial oxidation of codeine by Streptomyces griseus

  1985cited by this paper
• Metabolism of phencyclidine by microorganisms.

  1981cited by this paper
• Primaquine: metabolism by microorganisms and 13C nuclear magnetic resonance assignments

  1981cited by this paper
• Microbial transformations and 13C-NMR analysis of colchicine.

  1979cited by this paper
• Microbial hydroxylation of acronycine.

  1974cited by this paper
• Microbial transformation of methyl 5(6)-butyl-2-benzimidazolecarbamate.

  1974cited by this paper

• Pharmacogenomic and Pharmacomicrobiomic Aspects of Drugs of Abuse

  2025cites this paper
• Biotransformation of Ambrisentan by A. niger and P. mineoluteum Monitored by High Performance Liquid Chromatography and Ultra High Performance Liquid Chromatography/Quadrupole Time‐of‐Flight Mass Spectrometry

  2025cites this paper
• Structural determination and characterisation of the CYP105Q4 cytochrome P450 enzyme from Mycobacterium marinum.

  2024cites this paper
• Functional analysis of the whole CYPome and Fdxome of Streptomyces venezuelae ATCC 15439

  2024cites this paper
• Biotransformation of rifampicin by Aspergillus niger and antimicrobial activity of proposed metabolites.

  2024cites this paper
• 3-chloro-1,2-propanediol induces oxidative stress and promotes testicular damage and infertility in rats through CYP2C9.

  2024cites this paper
• Bacterial cytochrome P450 enzymes: Semi-rational design and screening of mutant libraries in recombinant Escherichia coli cells.

  2023cites this paper
• Efficient hydroxylation of flavonoids by using whole-cell P450 sca-2 biocatalyst in Escherichia coli

  2023cites this paper
• Engineering lanthipeptides by introducing a large variety of RiPP modifications to obtain new-to-nature bioactive peptides

  2023cites this paper
• Functional characterization of an efficient ibuprofen-mineralizing bacterial consortium.

  2023cites this paper
• Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap

  2022cites this paper
• Reviewing a plethora of oxidative-type reactions catalyzed by whole cells of Streptomyces species

  2022cites this paper
• Optimization of (–)-cubebin biotransformation to (–)-hinokinin by the marine fungus Absidia coerulea 3A9

  2021cites this paper
• Recombinant expression and characterization of novel P450s from Actinosynnema mirum.

  2021cites this paper
• More P450s Are Involved in Secondary Metabolite Biosynthesis in Streptomyces Compared to Bacillus, Cyanobacteria, and Mycobacterium

  2020cites this paper
• Enantioselective sulfoxidation using Streptomyces glaucescens GLA.0

  2020cites this paper
• The Metabolic Rainbow: Deep Learning Phase I Metabolism in Five Colors

  2020cites this paper
• Two‐step Screening for Identification of Drug‐metabolizing Bacterial Cytochromes P450 with Diversified Selectivity

  2020cites this paper
• Microbial metabolism of fluorinated drugs

  2019cites this paper
• A two-step lineage reprogramming strategy to generate functionally competent human hepatocytes from fibroblasts

  2019cites this paper
• Accessing the Biocatalytic Potential for C−H‐Activation by Targeted Genome Mining and Screening

  2019cites this paper
• Biotransformation of (-)-cubebin by Aspergillus spp. into (-)-hinokinin and (-)-parabenzlactone, and their evaluation against oral pathogenic bacteria

  2018cites this paper
• Microbial biotransformation – an important tool for the study of drug metabolism

  2018cites this paper
• Comparison of the florfenicol metabolic rate in Portunus trituberculatus individuals with different body weights

  2018cites this paper
• Streptomyces spp. in the biocatalysis toolbox

  2018cites this paper
• A novel cytochrome P450 mono‐oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450s

  2018cites this paper
• Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism.

  2017cites this paper
• Cytochromes P450 for natural product biosynthesis in Streptomyces: sequence, structure, and function.

  2017cites this paper
• Structural diversity of anti-pancreatic cancer capsimycins identified in mangrove-derived Streptomyces xiamenensis 318 and post-modification via a novel cytochrome P450 monooxygenase

  2017cites this paper
• Crystal Structure of Cytochrome P450 (CYP105P2) from Streptomyces peucetius and Its Conformational Changes in Response to Substrate Binding

  2016cites this paper
• Serum serotonin reduced the expression of hepatic transporter Mrp2 and P-gp via regulating nuclear receptor CAR in PI-IBS rats.

  2015cites this paper
• Characterization of the biosynthetic gene cluster for maklamicin, a spirotetronate-class antibiotic of the endophytic Micromonospora sp. NBRC 110955.

  2015cites this paper
• Structural basis for the 4′-hydroxylation of diclofenac by a microbial cytochrome P450 monooxygenase

  2015cites this paper
• 29-Deoxymaklamicin, a new maklamicin analogue produced by a genetically engineered strain of Micromonospora sp. NBRC 110955.

  2015cites this paper
• Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network

  2015cites this paper
• Targeted Fluorination of a Nonsteroidal Anti‐inflammatory Drug to Prolong Metabolic Half‐Life

  2014cites this paper
• Drug metabolism in microorganisms

  2014cites this paper